Security · CUSIP 55083R104
Lyell Immunopharma, Inc.
COM · institutional ownership from 13F filings
13F holders
1
Shares held
692.0K
Value held
$9.7M
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Decheng Capital LLC | 692,050 | $9.7M | 1.33% |
Biggest buyers
Nothing to show.
Biggest sellers
Nothing to show.